- Home
- ISSC vs AVTX Comparison
ISSC vs AVTX Comparison
Compare ISSC & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISSC | AVTX |
|---|---|---|
| Founded | 1988 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 380.6M | 328.4M |
| IPO Year | 2000 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ISSC | AVTX |
|---|---|---|
| Price | $17.19 | $15.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $18.25 | ★ $40.57 |
| AVG Volume (30 Days) | 523.8K | ★ 2.4M |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | 72.07 |
| EPS | ★ 0.41 | N/A |
| Revenue | N/A | ★ $27,813,137.00 |
| Revenue This Year | $7.95 | N/A |
| Revenue Next Year | $6.82 | N/A |
| P/E Ratio | $41.29 | ★ N/A |
| Revenue Growth | N/A | ★ 2312.27 |
| 52 Week Low | $8.13 | $3.93 |
| 52 Week High | $30.98 | $24.27 |
Technical Indicators
Market Signals| Indicator | ISSC | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 40.21 | 46.43 |
| Support Level | $15.07 | $15.33 |
| Resistance Level | $22.40 | $16.02 |
| Average True Range (ATR) | 1.15 | 1.26 |
| MACD | 0.04 | -0.36 |
| Stochastic Oscillator | 31.35 | 10.30 |
Price Performance
Historical ComparisonAbout ISSC Innovative Solutions and Support Inc.
Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.